VERA

Vera Therapeutics, Inc.

47.14 USD
+1.20 (+2.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vera Therapeutics, Inc. stock is up 36.6% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 Feb 15:56 20 Dec, 2024 35.00 PUT 125 0
01 Feb 20:53 16 Feb, 2024 40.00 CALL 200 490
01 Feb 20:58 16 Feb, 2024 30.00 CALL 41 579
02 Feb 15:22 20 Dec, 2024 55.00 CALL 63 0
02 Feb 15:26 20 Dec, 2024 55.00 CALL 36 0
02 Feb 19:24 15 Mar, 2024 35.00 PUT 197 447
02 Feb 20:39 21 Jun, 2024 35.00 PUT 135 156
09 Feb 18:28 16 Feb, 2024 35.00 CALL 48 966
15 Feb 20:46 16 Feb, 2024 25.00 CALL 40 566
22 Feb 20:26 19 Apr, 2024 40.00 PUT 189 2

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for immunoglobulin A nephropathy.